Form 4 · Filed Jul 1, 2026, 11:04 PM UTC
CTNM/Contineum Therapeutics, Inc.
Stengone Carmine N. — CEO and President
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | M | other | 7,500 | $1 | $7,575 | 24,717 |
| Jun 30, 2026 | M | other | 2,500 | $1 | $3,150 | 27,217 |
| Jun 30, 2026 | S | sell | 10,000 | $16 | $160,080 | 17,217 |
| Jun 30, 2026 | M | other | 7,500 | — | — | 281,930 |
| Jun 30, 2026 | M | other | 2,500 | — | — | 118,417 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-046653